PRECISION DELIVERY · B2B OEM & ODM PROJECTSEMAIL: info@hytanbio.com

CONFIGURATION / EVIDENCE / PROCUREMENT

Injection pen specifications: a buyer’s guide

Read injection pen capacity, dose increment, accuracy, connectivity and evidence requirements correctly, with official ISO and FDA references.

By the InjectionPen editorial team · Published and source-checked 28 October 2026 · Editorial standards

An injection pen specification should identify one device configuration, its container interface, dose scheme and evidence requirements. A body style, cartridge capacity or medicine name alone cannot establish compatibility or performance.

What belongs in an injection pen specification?

Record the exact device configuration and the intended supply boundary before comparing suppliers. Keep the container, dose mechanism, user tasks and required evidence in the same controlled record.

A quotation for an empty pen body differs from a proposal covering components, assembly, packaging or a complete medicinal presentation. Give each proposal a configuration identifier, drawing revision and list of exclusions. A supplier should be able to show which values come from an existing record, which are proposed targets and which still need engineering review. Use the configuration comparison to inspect catalog facts, then carry the selected record into the RFQ worksheet. A reference image helps describe appearance; it does not establish the mechanism hidden inside it.

  • Device and configuration identifier; document revision.
  • Container, closure, needle interface and relevant drawings.
  • Dose requirements and verification responsibilities.
  • Customization, supply scope, market and intended users.

Does cartridge capacity establish delivered dose?

No. Nominal cartridge capacity describes a container; delivered dose depends on the complete presentation and its validated performance. Usable fill, residual volume and the intended delivery scheme need separate definitions.

Two products described as “3 mL pens” can have different holders, closures, piston interfaces or setting mechanisms. A capacity label does not settle those interfaces. Ask for the exact container drawing and the proposed device baseline, then record how fit and function will be evaluated. A photographed container or a catalog dimension is useful context, but it is not a compatibility report. For a medicinal presentation, the formulation, concentration and approved instructions also matter. Keep technical procurement questions separate from patient dosing decisions; a business catalog cannot supply a treatment setting.

For a deeper interface checklist, use the 3 mL cartridge compatibility guide and confirm the exact reference before accepting a substitution.

How do dose range, increment and accuracy differ?

Dose range states the available setting span, while dose increment states the selectable step. Neither value, by itself, proves the accuracy of the amount delivered.

For example, the HB0001 configuration 1 catalog record lists a mechanical range of 1–60 units and a 1-unit increment. Those are reference values for that configuration, not a test result for every HB0001 option or every medicine. Accuracy needs an agreed evaluation basis, the relevant device and container revisions, operating conditions and an identifiable report. Do not replace missing evidence with the number printed in a dose window. Request the acceptance criteria and report scope from the responsible technical parties, rather than inventing a universal tolerance from a similar-looking pen.

Three terms to keep separate in an RFQ
TermWhat it describesWhat to request
RangeAvailable dose settingsExact configuration and calibration basis
IncrementSmallest selectable setting stepMechanism specification and setting behavior
AccuracyDelivered quantity against a defined targetTest conditions, acceptance basis and report

Can a unit setting be read as a milligram dose?

A unit setting cannot be treated as a universal milligram value. Its meaning depends on the specified presentation, concentration and device calibration.

This matters when an inquiry combines a peptide or insulin name with “injector pen.” A molecule name can refer to several presentations, and a body design can appear with several mechanisms. Record the intended concentration, container, setting scheme and responsible developer together. Do not infer interchangeability from matching exterior colors or capacity labels. The peptide and insulin presentation guides explain the questions that distinguish these inquiries; they are procurement references, not instructions for transferring a medicine into a different device. Any proposed medicinal configuration needs its own compatibility and market review.

Which digital functions should a connected-pen RFQ name?

Name the display, recorded event, storage behavior and transfer method separately. A memory display does not establish Bluetooth, NFC, app support or automatic treatment decisions.

HB0001 illustrates why configuration boundaries matter: its configuration 1 record describes NFC transfer and a history period, while another configuration has its own listed functions. The family name cannot safely carry every feature from both records. Ask whether an event represents a setting, actuation or confirmed delivery; these are different claims. Identify compatible software, supported operating systems, pairing or reading tasks, data ownership, updates and support responsibilities. Where software or connectivity is part of the project, include the associated risk and security work in the scope. Do not describe an undocumented app integration as an available feature.

Which standards and guidance should buyers review?

Review the standard and guidance editions relevant to the exact device, container and destination market. A standards list identifies a review framework; it does not certify a supplier or a product.

The public ISO scope for ISO 11608-1:2022 concerns needle-based injection systems for medical use; ISO 11608-3:2022 addresses containers and integrated fluid paths. Both have amendments published in April 2026. Record those amendments when agreeing the applicable baseline with the responsible technical parties. Do not assume the same scope covers every needle-free jet concept. FDA's human factors guidance, finalized in August 2026, addresses intended users, uses and environments. Its May 2026 companion addresses human factors information in marketing submissions. These sources help frame evidence requests; applicability and the complete requirements need project-specific review.

The quality and documentation page distinguishes company information, device evidence and market responsibilities. The dated reference register below links to the official source pages and records the editions checked.

What should an OEM buyer verify before approving a sample?

Approve a sample against a stated purpose and an identified configuration. An appearance sample supports an appearance decision; it cannot stand in for performance, compatibility or regulatory evidence.

For an engineering sample, agree the mechanism, container interface, dimensions, materials and evaluation plan before deciding what “accepted” means. List outstanding inputs, document revisions and the entity responsible for resolving each item. Record whether the sample represents a production process or an earlier prototype. If a component, packaging system or software function changes, ask how the change affects the evidence already collected. Keep the acceptance record attached to the quotation and selected configuration. This gives purchasing and technical teams a common reference when discussing deviations, pilot supply and later changes.

  • Sample purpose and configuration revision.
  • Evidence received, its scope and unresolved gaps.
  • Acceptance decision, conditions and responsible parties.
  • Change notification and approval route.

Supplier evidence checklist · Sample acceptance guide · Discuss a defined project

Sources and scope of this guide

This guide uses the public scope and official guidance pages linked below. It does not reproduce paid standards, supply test limits or establish conformity of a HYTANBIO configuration.

Official reference register · checked 28 October 2026

Download the dated reference register · CSV

Injection pen specification FAQ

Does a 3 mL cartridge make two injection pens interchangeable?

No. Nominal capacity does not establish dimensional fit, closure compatibility, needle connection, dose performance or suitability for a formulation. Review the exact cartridge drawing, device configuration and supporting evidence together.

Is a small dose increment evidence of dose accuracy?

No. The increment describes the selectable step. Accuracy concerns delivered quantity under defined conditions and requires a configuration-specific evaluation with an agreed acceptance basis.

Does a memory display mean the pen connects to an app?

No. A display, local event memory, NFC transfer and an app connection are different functions. Confirm each function for the selected configuration, including what event is recorded and which software is supported.

Can catalog values be used as a supplier approval record?

Catalog values are a starting record for an inquiry. Supplier approval requires the agreed configuration, document revisions, responsible entities and the evidence required for the intended project and market.

Your next delivery project
starts with a conversation.

Send your project brief